Alka-seltzer Plus Severe Cold Powerfast Fizz Night Tablet, Effervescent
NDC Package 0280-0021-01
Package Information
Alka-seltzer Plus Severe Cold Powerfast Fizz Night (aspirin, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine bitartrate) tablets is directions● adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water every 6 hours. This formulation utilizes a tablet, effervescent delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 0280-0021 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1536503 - aspirin 500 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
- RxCUI: 1536503 - aspirin 500 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
- RxCUI: 1536503 - ASA 500 MG / Dextromethorphan Hydrobromide 10 MG / doxylamine succinate 6.25 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Antihistamine - [EPC] (Established Pharmacologic Class)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Histamine Receptor Antagonists - [MoA] (Mechanism of Action)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0280 - Bayer Healthcare Llc.
- 0280-0021 - Alka-seltzer Plus Severe Cold Powerfast Fizz Night
- 0280-0021-01 - 10 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
- 0280-0021 - Alka-seltzer Plus Severe Cold Powerfast Fizz Night
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0280-0021-01 identifies a specific commercial package of 10 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Alka-seltzer Plus Severe Cold Powerfast Fizz Night, a human over the counter drug labeled by Bayer Healthcare Llc.. This tablet, effervescent is formulated for oral use and contains aspirin; dextromethorphan hydrobromide; doxylamine succinate; phenylephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on April 01, 2020. The current certification is valid through December 31, 2026.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280002101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.